Hypoxia-induced lncRNA PDIA3P1 promotes mesenchymal transition via sponging of miR-124-3p in glioma.
Shaobo WangYanhua QiXiao GaoWei QiuQinglin LiuXiaofan GuoMingyu QianZihang ChenZongpu ZhangHuizhi WangJianye XuHao XueXing GuoPing ZhangRongrong ZhaoGang LiPublished in: Cell death & disease (2020)
Hypoxia is a critical factor in the malignant progression of glioma, especially for the highly-invasive mesenchymal (MES) subtype. But the detailed mechanisms in hypoxia-induced glioma MES transition remain elusive. Pseudogenes, once considered to be non-functional relics of evolution, are emerging as a critical factor in human tumorigenesis and progression. Here, we investigated the clinical significance, biological function, and mechanisms of protein disulfide isomerase family A member 3 pseudogene 1 (PDIA3P1) in hypoxia-induced glioma MES transition. In this study, we found that PDIA3P1 expression was closely related to tumor degree, transcriptome subtype, and prognosis in glioma patients. Enrichment analysis found that high PDIA3P1 expression was associated with epithelial-mesenchymal transition, extracellular matrix (ECM) disassembly, and angiogenesis. In vitro study revealed that overexpression of PDIA3P1 enhanced the migration and invasion capacity of glioma cells, while knockdown of PDIA3P1 induced the opposite effect. Further studies revealed that PDIA3P1 functions as a ceRNA, sponging miR-124-3p to modulate RELA expression and activate the downstream NF-κB pathway, thus promoting the MES transition of glioma cells. In addition, Hypoxia Inducible Factor 1 was confirmed to directly bind to the PDIA3P1 promotor region and activate its transcription. In conclusion, PDIA3P1 is a crucial link between hypoxia and glioma MES transition through the PDIA3P1-miR-124-3p-RELA axis, which may serve as a prognostic indicator and potential therapeutic target for glioma treatment.
Keyphrases
- endothelial cells
- extracellular matrix
- poor prognosis
- epithelial mesenchymal transition
- stem cells
- end stage renal disease
- long non coding rna
- single cell
- bone marrow
- oxidative stress
- risk assessment
- high glucose
- chronic kidney disease
- prognostic factors
- climate change
- peritoneal dialysis
- genome wide
- rna seq
- dna methylation
- long noncoding rna
- nuclear factor
- patient reported outcomes
- vascular endothelial growth factor
- toll like receptor
- combination therapy
- stress induced
- smoking cessation
- pluripotent stem cells